GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (OTCPK:INRLF) » Definitions » Cyclically Adjusted Book per Share

Valneva SE (Valneva SE) Cyclically Adjusted Book per Share : $1.68 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Valneva SE Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Valneva SE's adjusted book value per share for the three months ended in Mar. 2024 was $1.478. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.68 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Valneva SE's average Cyclically Adjusted Book Growth Rate was -10.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Valneva SE was -0.80% per year. The lowest was -2.00% per year. And the median was -1.40% per year.

As of today (2024-05-25), Valneva SE's current stock price is $4.328. Valneva SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $1.68. Valneva SE's Cyclically Adjusted PB Ratio of today is 2.58.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Valneva SE was 14.50. The lowest was 1.16. And the median was 3.49.


Valneva SE Cyclically Adjusted Book per Share Historical Data

The historical data trend for Valneva SE's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Cyclically Adjusted Book per Share Chart

Valneva SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 2.18 1.90 1.84 1.75

Valneva SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 2.22 1.85 1.75 1.68

Competitive Comparison of Valneva SE's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Valneva SE's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Valneva SE's Cyclically Adjusted PB Ratio falls into.



Valneva SE Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Valneva SE's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.478/119.4700*119.4700
=1.478

Current CPI (Mar. 2024) = 119.4700.

Valneva SE Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.499 100.180 4.173
201409 2.366 99.920 2.829
201412 2.057 99.860 2.461
201503 2.299 100.170 2.742
201506 2.272 100.440 2.702
201509 2.182 99.950 2.608
201512 2.105 100.040 2.514
201603 2.084 100.020 2.489
201606 1.512 100.630 1.795
201609 1.414 100.340 1.684
201612 1.342 100.650 1.593
201703 1.353 101.170 1.598
201706 1.402 101.320 1.653
201709 1.458 101.330 1.719
201712 1.416 101.850 1.661
201803 1.485 102.750 1.727
201806 1.366 103.370 1.579
201809 1.332 103.560 1.537
201812 1.792 103.470 2.069
201903 1.710 103.890 1.966
201906 1.618 104.580 1.848
201909 1.576 104.500 1.802
201912 1.654 104.980 1.882
202003 1.600 104.590 1.828
202006 1.376 104.790 1.569
202009 0.994 104.550 1.136
202012 1.037 104.960 1.180
202103 0.680 105.750 0.768
202106 0.931 106.340 1.046
202109 0.000 106.810 0.000
202112 1.835 107.850 2.033
202203 0.000 110.490 0.000
202206 0.841 112.550 0.893
202209 1.392 112.740 1.475
202212 1.683 114.160 1.761
202303 1.586 116.790 1.622
202306 1.489 117.650 1.512
202309 1.211 118.260 1.223
202312 1.008 118.390 1.017
202403 1.478 119.470 1.478

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Valneva SE  (OTCPK:INRLF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Valneva SE's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.328/1.68
=2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Valneva SE was 14.50. The lowest was 1.16. And the median was 3.49.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Valneva SE Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Valneva SE's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE (Valneva SE) Business Description

Industry
Traded in Other Exchanges
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, & third-party products; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The majority is from the Commercialized vaccines segment & geographically from the United States.